3484-67-1 (4-O-氨基甲酰基-2-脱氧-2-{[(3S,10S,17S,24S,31S,38S)-3,10,17,24,31,38,41-七氨基-8,15,22,29,36-五氧代-7,14,21,28,35-五氮杂苯基四环素-1-酰基]氨基}-N-[(3aS,7R,7aS)-7-羟基-4-氧代-3a,4,5,6,7,7a-六氢-1H-咪唑并[4,5-c]吡啶-2-基]-β-D-古洛比,4-O-carbamoyl-2-deoxy-2-{[(3S,10S,17S,24S,31S,38S)-3,10,17,24,31,38,41-heptaamino-8,15,22,29,36-pentaoxo-7,14,21,28,35-pentaazahentetracontan-1-oyl]amino}-N-[(3aS,7R,7aS)-7-hydroxy-4-oxo-3a,4,5,6,7,7a-hexahydro-1H-imidazo[4,5-c]pyridin-2-yl]-beta-D-gulopy)

CAS号:
3484-67-1
中文名称:
4-O-氨基甲酰基-2-脱氧-2-{[(3S,10S,17S,24S,31S,38S)-3,10,17,24,31,38,41-七氨基-8,15,22,29,36-五氧代-7,14,21,28,35-五氮杂苯基四环素-1-酰基]氨基}-N-[(3aS,7R,7aS)-7-羟基-4-氧代-3a,4,5,6,7,7a-六氢-1H-咪唑并[4,5-c]吡啶-2-基]-β-D-古洛比
英文名称:
4-O-carbamoyl-2-deoxy-2-{[(3S,10S,17S,24S,31S,38S)-3,10,17,24,31,38,41-heptaamino-8,15,22,29,36-pentaoxo-7,14,21,28,35-pentaazahentetracontan-1-oyl]amino}-N-[(3aS,7R,7aS)-7-hydroxy-4-oxo-3a,4,5,6,7,7a-hexahydro-1H-imidazo[4,5-c]pyridin-2-yl]-beta-D-gulopy
分子式:
C49H94N18O13
分子量:
1143.38347005844

4-O-氨基甲酰基-2-脱氧-2-{[(3S,10S,17S,24S,31S,38S)-3,10,17,24,31,38,41-七氨基-8,15,22,29,36-五氧代-7,14,21,28,35-五氮杂苯基四环素-1-酰基]氨基}-N-[(3aS,7R,7aS)-7-羟基-4-氧代-3a,4,5,6,7,7a-六氢-1H-咪唑并[4,5-c]吡啶-2-基]-β-D-古洛比(3484-67-1)名称与标识符

名称

英文别名:
4-O-carbamoyl-2-deoxy-2-{[(3S,10S,17S,24S,31S,38S)-3,10,17,24,31,38,41-heptaamino-8,15,22,29,36-pentaoxo-7,14,21,28,35-pentaazahentetracontan-1-oyl]amino}-N-[(3aS,7R,7aS)-7-hydroxy-4-oxo-3a,4,5,6,7,7a-hexahydro-1H-imidazo[4,5-c]pyridin-2-yl]-beta-D-gulopy;4-O-carbamoyl-2-deoxy-2-{[(3S,10S,17S,24S,31S,38S)-3,10,17,24,31,38,41-heptaamino-8,15,22,29,36-pentaoxo-7,14,21,28,35-pentaazahentetracontan-1-oyl]amino}-N-[(3aS,7R,7aS)-7-hydroxy-4-oxo-3a,4,5,6,7,7a;Streptothricin A;CHEMBL4460958;Imidazo(4,5-c)pyridin-4-one, 2-((2-(3-amino-6-(3-amino-6-(3-amino-6-(3-amino-6-(3-amino-6-(3,6-diaminohexanamido)hexanamido)hexanamido)hexanamido)hexanamido)hexanamido)-2-deoxy-alpha-D-gulopyranosyl)amino)-3,3a,5,6,7,7a-hexahydro-7-hydroxy-, 6'-carbamate;3484-67-1;CHEBI:220224;

标识符

InChIKey:
CTKOCMSLRIIOBG-JMSRUVCGSA-N
Inchi:
1S/C49H94N18O13/c50-13-1-7-27(51)19-35(70)58-14-2-8-28(52)20-36(71)59-15-3-9-29(53)21-37(72)60-16-4-10-30(54)22-38(73)61-17-5-11-31(55)23-39(74)62-18-6-12-32(56)24-40(75)64-43-44(76)45(80-48(57)78)34(26-68)79-47(43)67-49-65-41-33(69)25-63-46(77)42(41)66-49/h27-34,41-45,47,68-69,76H,1-26,50-56H2,(H2,57,78)(H,58,70)(H,59,71)(H,60,72)(H,61,73)(H,62,74)(H,63,77)(H,64,75)(H2,65,66,67)/t27-,28-,29-,30-,31-,32-,33+,34+,41+,42-,43+,44-,45-,47+/m0/s1
SMILES:
O1[C@H](CO)[C@@H]([C@H]([C@H]([C@@H]1NC1=N[C@@H]2C(NC[C@H]([C@H]2N1)O)=O)NC(C[C@H](CCCNC(C[C@H](CCCNC(C[C@H](CCCNC(C[C@H](CCCNC(C[C@H](CCCNC(C[C@H](CCCN)N)=O)N)=O)N)=O)N)=O)N)=O)N)=O)O)OC(N)=O

4-O-氨基甲酰基-2-脱氧-2-{[(3S,10S,17S,24S,31S,38S)-3,10,17,24,31,38,41-七氨基-8,15,22,29,36-五氧代-7,14,21,28,35-五氮杂苯基四环素-1-酰基]氨基}-N-[(3aS,7R,7aS)-7-羟基-4-氧代-3a,4,5,6,7,7a-六氢-1H-咪唑并[4,5-c]吡啶-2-基]-β-D-古洛比(3484-67-1)物化性质

计算特性

  • 精确分子量 : 1142.72477513g/mol
  • 氢键供体数量 : 20
  • 氢键受体数量 : 21
  • 可旋转化学键数量 : 41
  • 同位素质量 : 1142.72477513g/mol
  • 重原子数量 : 80
  • 复杂度 : 1980
  • 同位素原子数量 : 0
  • 确定原子立构中心数量 : 14
  • 不确定原子立构中心数量 : 0
  • 确定化学键立构中心数量 : 0
  • 不确定化学键立构中心数量 : 0
  • 共价键单元数量 : 1
  • 疏水参数计算参考值(XlogP) : -10
  • 拓扑分子极性表面积 : 545Ų

4-O-氨基甲酰基-2-脱氧-2-{[(3S,10S,17S,24S,31S,38S)-3,10,17,24,31,38,41-七氨基-8,15,22,29,36-五氧代-7,14,21,28,35-五氮杂苯基四环素-1-酰基]氨基}-N-[(3aS,7R,7aS)-7-羟基-4-氧代-3a,4,5,6,7,7a-六氢-1H-咪唑并[4,5-c]吡啶-2-基]-β-D-古洛比(3484-67-1)相关文献